Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants

Plastic and Reconstructive Surgery

Volumn 114, Issue 1, 2004, Pages 229-236

  Ulrich, Dietmar ^a,b   Lichtenegger, Franziska ^a   Eblenkamp, Markus ^a   Repper, Dimitrios ^a   Pallua, Norbert ^a  

^a Aachen University of Technology ^*

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; HYALURONIC ACID; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE III N TERMINAL PEPTIDE; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE;

ADULT; ALLOGRAFT; ARTICLE; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST FIBROSIS; BREAST REDUCTION; CAPSULAR CONTRACTURE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROTEIN BLOOD LEVEL; RANK SUM TEST; STATISTICAL ANALYSIS; BLOOD; BREAST; BREAST RECONSTRUCTION; COMPARATIVE STUDY; PATHOLOGY;

ADULT; BIOLOGICAL MARKERS; BREAST; BREAST IMPLANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MAMMAPLASTY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; PEPTIDE FRAGMENTS; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 3142720586     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000129079.19089.6C     Document Type: Article

References (28)

1. Burckhardt, B. R. Capsular contracture: Hard breasts, soft data. Clin. Plast. Surg. 15: 521, 1988.
2. Maxwell, G. P., and Lugston, P. A. Management of complications following augmentation mammaplasty. In G. S. Georgeade, R. Riefkohl, and L. S. Levin (Eds.), Georgeade Plastic, Maxillofacial and Reconstructive Surgery, 3rd Ed. Baltimore, Md.: Williams & Wilkins, 1997.
3. Vistnes, L. M., Ksander, G. A., and Kosek, J. Study of encapsulation of silicone rubber implant in animals: A foreign-body reaction. Plast. Reconstr. Surg. 62: 580, 1978.
4. Ginsbach, G., Busch, L. C., and Kühnel, W. The nature of the collagenous capsules around breast implants: Light and electron microscopic investigations. Plast. Reconstr. Surg. 64: 456, 1979.
5. Baker, J. L., Jr., Chandler, M. L., and LeVier, R. R. Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast. Reconstr. Surg. 68: 905, 1981.
6. Lossing, C., and Hansson, H-A. Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast. Reconstr. Surg. 91: 1277, 1993.
7. Armstrong, D. G., and Jude, E. B. The role of matrix metalloproteinases in wound healing. J. Am. Podiatr. Med. Assoc. 92: 12, 2002.
8. Ravanti, L., and Kahari, V. M. Matrix metalloproteinases in wound repair. Int. J. Mol. Med. 6: 391, 2000.
9. Brew, K., Dinakarpandian, D., and Nagase, H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta 1477: 267, 2002.
10. Lichtinghagen, R., Michels, D., Heberkorn, C. I., et al. Matrix metalloproteinase MMP-2, MMP-7, and tissue inhibitor of metalloproteinase are closely related to fibroproliferative process in the liver during chronic hepatitis C. J. Hepatol. 34: 239, 2001.
11. Ulrich, D., Noah, E. M., von Heimburg, D., and Pallua, N. TIMP-1, MMP-2, -9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast. Reconstr. Surg. 111: 1423, 2003.
12. Siggelkow, W., Faridi, A., Spiritus, K., et al. Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials 24: 1101, 2003.
13. Yeoh, G., Russell, P., and Jenkins, E. Spectrum of histological changes reactive to prosthetic breast implants: A clinicopathological study of 84 patients. Pathology 28: 232, 1996.
14. Rosenbaum, D., Peric, S., Holecek, M., and Ward, H. E. Hyaluronan in radiation-induced lung disease in the rat. Radiat. Res. 147: 585, 1997.
15. Medical Devices Agency. Trilucent Breast Implants: Recommendation to Remove. MDA HN2000(05), 20000211.011-31, June 2000.
16. Rumalla, V. K., and Borah, G. L. Cytokines, growth factors, and plastic surgery. Plast. Reconstr. Surg. 108: 719, 2001.
17. Arthur, M. J. Fibrosis and altered matrix degradation. Digestion 59: 376, 1998.
18. Reynolds, J. J. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis. 2: 70, 1996.
19. Saito, S., Trovato, M., You, R., et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase 1 in chronic venous insufficiency. J. Vasc. Surg. 34: 930, 2001.
20. Ersek, R. Rate and incidence of capsular contracture: A comparison of smooth and textured silicone double lumen breast prosthesis. Plast. Reconstr. Surg. 87: 879, 1991.
21. Ulrich, D., Hrynyschyn, K., and Pallua, N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plast. Reconstr. Surg. 112: 1279, 2003.
22. Choudhary, S., Cadier, M. A., and Cottrell, B. J. Local tissue reactions to oil-based breast implant bleed. Br. J. Plast. Surg. 53: 317, 2000.
23. McArthur, P. A., Green, A. R., Hancock, K., and Green, A. R. Histological examination of the capsules surrounding Trilucent breast implants. Br. J. Plast. Surg. 54: 684, 2001.
24. Zachariae, H., Heickendorff, L. L., and Sogaard, H. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: A 10-year follow-up. Br. J. Dermatol. 144: 100, 2001.
25. Ulrich, D., Noah, E. M., Burchardt, E. R., Atkins, D., and Pallua, N. Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients. Burns 28: 766, 2002.
26. Stickel, F., Urbaschek, R., Schuppan, D., et al. Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease. Dig. Dis. Sci. 46: 2025, 2001.
27. Sundstrom, G., Lofvenberg, E., Hassan, I., and Engstrom-Laurent, A. Localisation and distribution of hyaluronan in normal bone marrow matrix: A novel method to evaluate impending fibrosis? Eur. J. Haematol. 68: 194, 2002.
28. Tran, A., Hastier, P., Barjoan, E. M., et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol. Clin. Biol. 24: 626, 2000.